<DOC>
	<DOCNO>NCT00837616</DOCNO>
	<brief_summary>Estrogen necessary feminization puberty decrease bone resorption , latter critical achievement peak bone mass normal bone health female . The practice pediatric endocrinologist often face dilemma best feminize girl hypogonadism ( lack estrogen ) , manifest delay arrest puberty , due disorder brain ovary . We propose series study address type , dose , route delivery estrogen suitable choice feminize sustain estrogen concentration adolescent girl Turner syndrome . To accomplish study girls/young woman age 13 20 Turner Syndrome 2 protocol . In Protocol # 1 study 24 girl TS , receive 3 different estrogen preparation , either mouth via patch total 6 week . They come clinical research center blood draws 2 wks take estrogen . With study , hope learn body responds estrogen differently , depend form estrogen give high , estrogen level get blood girl Turner Syndrome . We compare patient estrogen level girls menstruate normally Turner Syndrome . In Protocol # 2 , 40 patient TS recruit ; patient take estrogen 1 year , either mouth via patch . Patients come lab blood drawn 7 occasion measure estrogen level well hormone lipid level . We also perform Dual-energy X-ray absorptiometry ( DXA ) study ( like X ray ) ass body composition bone mineralization . We adjust dos base estrogen level find . With study hope learn estrogen affect body composition , i.e. , amount fat vs. muscle , different form estrogen affect blood cholesterol hormone . This study allow u understand good best replace young woman Turner Syndrome estrogen .</brief_summary>
	<brief_title>Estrogen Dosing Turner Syndrome : Pharmacology Metabolism</brief_title>
	<detailed_description>Data specific effect bioequivalency different form estrogen lacking , young adolescent age group particular , virtually non-existent . This complicate difficulty accurately interpret estradiol assay result conventional radioimmunoassay ( RIA ) estradiol inaccurate insensitive measure small concentration plasma . There wide variation type estrogen use estrogen replacement , well dose route administration . Girls Turner syndrome ( TS ) represent important case study issue early primary gonadal insufficiency failure many year achievement peak bone mass . Hence , study effect different estrogen compound patient population offer unique model eliminate confound effect product produce intact gonad . Since condition imperative estrogen replacement start adolescent year continue several decade , issue become highly relevant young woman 's health.Our specific aim : 1. characterize pharmacokinetics ( PK ) pharmacodynamics ( PD ) relative biological potency different oral vs. transdermal preparation estradiol use state-of-the-art tandem mass spectrometry assay recombinant cell bioassay ; 2. investigate differential , long term metabolic effect oral vs. transdermal estrogen replacement , specifically effect lipid protein metabolism well body composition patient population ; 3. determine feasibility estrogen concentration-based dose puberty 4 . To characterize metabolic profile TS girls previously treat GH . To accomplish study girls/young woman age 13 20 TS 2 protocol . Protocol # 1 study pharmacokinetic/pharmacodynamic ( PK/PD ) 3 different preparation estrogen different dos . Protocol # 2 one year longitudinal study effect oral vs. transdermal ( TD ) estrogen body composition , hormone growth factor .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Girls Turner Syndrome ( 45X , relate karyotype ) diagnose clinically cytogenetically Female subject Y material allow provide gonadectomies perform previously Age : 1320 year Subjects complete nearly complete linear growth Previous growth hormone ( GH ) therapy discontinue least 6 month prior study participation Stable thyroid replacement therapy allow Celiac disease stable diet allow Any previous hormone replacement therapy ( HRT ) allow Diabetes Mellitus insulin therapy , insulin sensitizer oral hypoglycemics Inflammatory Bowel Disease ( ulcerative colitis Crohn 's disease ) , celiac disease Cigarette smoking Any chronic condition , , opinion investigator could impair metabolism nutrient Severe obesity , i.e. , Body Mass Index ( BMI ) &gt; 95th centile</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Turner Syndrome</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>GH</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Estrogen Patches</keyword>
	<keyword>IGF-I</keyword>
	<keyword>Body Composition</keyword>
	<keyword>Protein Metabolism</keyword>
	<keyword>Lipid Oxidation</keyword>
	<keyword>Estradiol assay LCMSMS</keyword>
	<keyword>Recombinant Cell Bioassay</keyword>
</DOC>